4"修饰的阿齐思罗米衍生物含有含的异环,具有双重抑制活性
Maksim M Martynov1, Inna A Volynkina2, Natalia E Grammatikova1
1Gause Institute of New Antibiotics, 119021 Moscow, Russia.
Bioorganic chemistry
|December 23, 2025
概括
具有异环变异的新型阿齐思罗米衍生物与抗微生物耐药性作斗争. 这些化合物通过规避常见的耐药机制,对抗耐药细菌表现出增强的活性,为抗宏类耐药性提供了一个有前途的战略.
科学领域:
- 药用化学 医学化学
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
背景情况:
- 抗微生物耐药性 (AMR) 是一个日益增长的全球健康威胁,需要新的策略来打击细菌感染.
- 宏类抗生素,如阿齐思罗米,至关重要,但面临越来越多的耐药性,限制了它们的临床效用.
研究的目的:
- 设计和合成新型阿齐思罗米衍生物,以克服宏类抗药性.
- 评估这些新化合物对抗性细菌菌株的抗菌活性和作用机制.
主要方法:
- 通过不同的链接器,在4"位置合成具有多种aza-heterocycles的阿齐思罗米衍生物.
- 在体外评估抗菌活性与参考和临床细菌分离物相比.
- 机理学研究包括细菌翻译抑制和DNA拓酶活性测试.
主要成果:
- 几种衍生物,特别是5e-g,表现出对格拉姆阳性细菌的优越活性,衍生物5f显示出改善的治疗指数.
- 化合物抑制了细菌的翻译,一些化合物干扰了DNA拓酶.
- 活动与ERM和MEF介导的耐药性菌株保持一致,绕过了核糖体修饰和排泄.
结论:
- 合理的4"位置异环修饰阿齐思罗米可以产生下一代宏类.
- 这些衍生品表现出增强的活性,双重的作用机制,以及对抗性决定因素的敏感性降低.
- 这些化合物显示出克服可诱导的宏类抗性机制的潜力,而不会诱导 ermC 表达.
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
879
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
879
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.7K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.7K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K


